About
Bobby Gaspar is a physician and scientist with over 25 years of experience in medicine and biotechnology, serving as a Venture Partner at F-Prime Capital. He is a scientific founder and CEO of Orchard Therapeutics, a gene therapy company acquired by Kyowa Kirin, and has worked extensively on hematopoietic stem cell gene therapy for primary immune deficiencies. He is an honorary professor of pediatrics and immunology at UCL's Great Ormond Street Institute of Child Health, studied medicine and surgery at King's College London, and completed his PhD at UCL.
Invests in
Biotech
Experience
- Orchard TherapeuticsChief Executive Officercurrent2020 β presentLondon
- Orchard TherapeuticsFounder and Chief Scientific Officer2018 β 2020London
- University College LondonProfessor of Paediatrics and Immunologycurrent1993 β present
Shared employers
Also worked at Orchard Therapeutics3
Also worked at University College London42
Itxaso del PalacioGeneral Partner at Notion CapitalTess van StekelenburgPartner at Lux CapitalFrancesco MonacaInvestor at Giant Ventures Global LlpDima KuzminManaging Partner at 4BIO CapitalDamian Crowtherex-AstraZeneca at PICUS CAPITALAlexander Sinclair-Wilsonζ§θ‘θ£δΊ at Qiming Venture Partners
+ 36 more
Investments
Board seats
Eligo Biosciences
Per the firm's website.
Colleagues at F-Prime Capital Partners
Abby Wagner
Senior Accountant at F-Prime Capital Partners
Abdul Abdirahman
Principal at F-Prime Capital Partners
Alex Wong
Associate at F-Prime Capital Partners
Alexander Pasteur
Partner at F-Prime Capital Partners
Allan Galper
Vice President & Associate General Counsel at F-Prime Capital Partners
Allison MacLeod
Venture Partner at F-Prime Capital Partners
Amber Cai
Venture Partner at F-Prime Capital Partners
Andrew Bognanni
Director of Finance at F-Prime Capital Partners